1. Antigen-specific age-related memory CD8 T cells induce and track Alzheimer's-like neurodegeneration.
- Author
-
Panwar, Akanksha, Rentsendorj, Altan, Jhun, Michelle, Cohen, Robert M., Cordner, Ryan, Gull, Nicole, Pechnick, Robert N., Duvall, Gretchen, Mardiros, Armen, Golchian, David, Schubloom, Hannah, Lee-Way Jin, Van Dam, Debby, Vermeiren, Yannick, De Reu, Hans, De Deyn, Peter Paul, Raskatov, Jevgenij A., Black, Keith L., Irvin, Dwain K., and Williams, Brian A.
- Subjects
ALZHEIMER'S disease ,T cells ,IMMUNOLOGIC memory ,NEURODEGENERATION ,BRAIN injuries - Abstract
Cerebral (Aβ) plaque and (pTau) tangle deposition are hallmarks of Alzheimer's disease (AD), yet are insufficient to confer complete AD-like neurodegeneration experimentally. Factors acting upstream of Aβ/pTau in AD remain unknown, but their identification could enable earlier diagnosis and more effective treatments. T cell abnormalities are emerging AD hallmarks, and CD8 T cells were recently found to mediate neurodegeneration downstream of tangle deposition in hereditary neurodegeneration models. The precise impact of T cells downstream of Aβ/pTau, however, appears to vary depending on the animal model. Our prior work suggested that antigen-specific memory CD8 T ("hiT") cells act upstream of Aβ/pTau after brain injury. Here, we examine whether hiT cells influence sporadic AD-like pathophysiology upstream of Aβ/pTau. Examining neuropathology, gene expression, and behavior in our hiT mouse model we show that CD8 T cells induce plaque and tangle-like deposition, modulate AD-related genes, and ultimately result in progressive neurodegeneration with both gross and fine features of sporadic human AD. T cells required Perforin to initiate this pathophysiology, and IFNγ for most gene expression changes and progression to more widespread neurodegenerative disease. Analogous antigen-specific memory CD8 T cells were significantly elevated in the brains of human AD patients, and their loss from blood corresponded to sporadic AD and related cognitive decline better than plasma pTau-217, a promising AD biomarker candidate. We identify an age-related factor acting upstream of Aβ/pTau to initiate AD-like pathophysiology, the mechanisms promoting its pathogenicity, and its relevance to human sporadic AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF